FY2025 EPS Estimates for Bruker Co. Decreased by Zacks Research (NASDAQ:BRKR)

Bruker Co. (NASDAQ:BRKR) – Zacks Research cut their FY2025 earnings per share estimates for Bruker in a research note issued to investors on Wednesday, September 18th. Zacks Research analyst R. Department now anticipates that the medical research company will post earnings per share of $3.07 for the year, down from their prior forecast of $3.09. The consensus estimate for Bruker’s current full-year earnings is $2.61 per share. Zacks Research also issued estimates for Bruker’s FY2026 earnings at $3.64 EPS.

A number of other equities research analysts also recently commented on BRKR. TD Cowen reduced their target price on Bruker from $74.00 to $72.00 and set a “hold” rating for the company in a report on Wednesday, August 7th. The Goldman Sachs Group decreased their price target on Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a research note on Tuesday, July 9th. Citigroup dropped their price objective on Bruker from $95.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, July 10th. Jefferies Financial Group started coverage on shares of Bruker in a research note on Monday, June 3rd. They issued a “buy” rating and a $85.00 price objective on the stock. Finally, Wells Fargo & Company assumed coverage on Bruker in a report on Tuesday, August 27th. They set an “overweight” rating and a $78.00 target price on the stock. One research analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, Bruker has a consensus rating of “Moderate Buy” and an average price target of $81.40.

Bruker Stock Performance

NASDAQ BRKR opened at $67.54 on Friday. The company has a fifty day moving average of $64.56 and a two-hundred day moving average of $72.76. Bruker has a 1 year low of $53.79 and a 1 year high of $94.86. The company has a market capitalization of $9.82 billion, a PE ratio of 24.56, a P/E/G ratio of 2.31 and a beta of 1.18. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.65 and a quick ratio of 0.75.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings data on Tuesday, August 6th. The medical research company reported $0.52 EPS for the quarter, hitting the consensus estimate of $0.52. Bruker had a return on equity of 24.92% and a net margin of 11.29%. The company had revenue of $800.70 million during the quarter, compared to analyst estimates of $799.44 million. During the same period in the previous year, the business earned $0.50 EPS. Bruker’s quarterly revenue was up 17.4% on a year-over-year basis.

Institutional Investors Weigh In On Bruker

Hedge funds have recently bought and sold shares of the company. Norges Bank bought a new position in Bruker during the 4th quarter worth $74,582,000. Marshall Wace LLP grew its stake in Bruker by 127.8% during the second quarter. Marshall Wace LLP now owns 1,389,537 shares of the medical research company’s stock worth $88,666,000 after buying an additional 779,549 shares in the last quarter. Point72 Asset Management L.P. acquired a new stake in Bruker during the second quarter worth about $36,472,000. TD Asset Management Inc raised its position in shares of Bruker by 51.1% in the 4th quarter. TD Asset Management Inc now owns 1,664,779 shares of the medical research company’s stock valued at $122,328,000 after buying an additional 562,684 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado raised its position in Bruker by 925.8% during the fourth quarter. Public Employees Retirement Association of Colorado now owns 362,035 shares of the medical research company’s stock valued at $26,602,000 after purchasing an additional 326,741 shares in the last quarter. 79.52% of the stock is currently owned by institutional investors and hedge funds.

Bruker Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Monday, September 2nd were issued a dividend of $0.05 per share. The ex-dividend date of this dividend was Friday, August 30th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.30%. Bruker’s payout ratio is presently 7.27%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.